Global Enbrel (Etanercept) and Biosimilar Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Enbrel (Etanercept) and Biosimilar market size was valued at USD 6533.8 million in 2022 and is forecast to a readjusted size of USD 8122.5 million by 2029 with a CAGR of 3.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Etanercept is a medication used to manage and treat autoimmune conditions such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, and ankylosing spondylitis. It is a biologic fusion protein in the TNF blocker class of medications.
This report is a detailed and comprehensive analysis for global Enbrel (Etanercept) and Biosimilar market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Enbrel (Etanercept) and Biosimilar market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Enbrel (Etanercept) and Biosimilar market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Enbrel (Etanercept) and Biosimilar market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Enbrel (Etanercept) and Biosimilar market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Enbrel (Etanercept) and Biosimilar
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Enbrel (Etanercept) and Biosimilar market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Amgen, Samsung Bioepis, Novartis and 3s Bio and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Enbrel (Etanercept) and Biosimilar market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Enbrel (Etanercept) and Biosimilar product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Enbrel (Etanercept) and Biosimilar, with price, sales, revenue and global market share of Enbrel (Etanercept) and Biosimilar from 2018 to 2023.
Chapter 3, the Enbrel (Etanercept) and Biosimilar competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Enbrel (Etanercept) and Biosimilar breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Enbrel (Etanercept) and Biosimilar market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Enbrel (Etanercept) and Biosimilar.
Chapter 14 and 15, to describe Enbrel (Etanercept) and Biosimilar sales channel, distributors, customers, research findings and conclusion.
Etanercept is a medication used to manage and treat autoimmune conditions such as plaque psoriasis, rheumatoid arthritis, psoriatic arthritis, juvenile idiopathic arthritis, and ankylosing spondylitis. It is a biologic fusion protein in the TNF blocker class of medications.
This report is a detailed and comprehensive analysis for global Enbrel (Etanercept) and Biosimilar market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Enbrel (Etanercept) and Biosimilar market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Enbrel (Etanercept) and Biosimilar market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Enbrel (Etanercept) and Biosimilar market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Enbrel (Etanercept) and Biosimilar market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Enbrel (Etanercept) and Biosimilar
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Enbrel (Etanercept) and Biosimilar market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Pfizer, Amgen, Samsung Bioepis, Novartis and 3s Bio and etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Enbrel (Etanercept) and Biosimilar market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Syringe
- Pen
- Hospital
- Pharmacy
- Other
- Pfizer
- Amgen
- Samsung Bioepis
- Novartis
- 3s Bio
- Lupin
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Enbrel (Etanercept) and Biosimilar product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Enbrel (Etanercept) and Biosimilar, with price, sales, revenue and global market share of Enbrel (Etanercept) and Biosimilar from 2018 to 2023.
Chapter 3, the Enbrel (Etanercept) and Biosimilar competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Enbrel (Etanercept) and Biosimilar breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Enbrel (Etanercept) and Biosimilar market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Enbrel (Etanercept) and Biosimilar.
Chapter 14 and 15, to describe Enbrel (Etanercept) and Biosimilar sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Enbrel (Etanercept) and Biosimilar
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Enbrel (Etanercept) and Biosimilar Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Syringe
1.3.3 Pen
1.4 Market Analysis by Application
1.4.1 Overview: Global Enbrel (Etanercept) and Biosimilar Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Pharmacy
1.4.4 Other
1.5 Global Enbrel (Etanercept) and Biosimilar Market Size & Forecast
1.5.1 Global Enbrel (Etanercept) and Biosimilar Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Enbrel (Etanercept) and Biosimilar Sales Quantity (2018-2029)
1.5.3 Global Enbrel (Etanercept) and Biosimilar Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Enbrel (Etanercept) and Biosimilar Product and Services
2.1.4 Pfizer Enbrel (Etanercept) and Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Enbrel (Etanercept) and Biosimilar Product and Services
2.2.4 Amgen Enbrel (Etanercept) and Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Amgen Recent Developments/Updates
2.3 Samsung Bioepis
2.3.1 Samsung Bioepis Details
2.3.2 Samsung Bioepis Major Business
2.3.3 Samsung Bioepis Enbrel (Etanercept) and Biosimilar Product and Services
2.3.4 Samsung Bioepis Enbrel (Etanercept) and Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Samsung Bioepis Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Enbrel (Etanercept) and Biosimilar Product and Services
2.4.4 Novartis Enbrel (Etanercept) and Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novartis Recent Developments/Updates
2.5 3s Bio
2.5.1 3s Bio Details
2.5.2 3s Bio Major Business
2.5.3 3s Bio Enbrel (Etanercept) and Biosimilar Product and Services
2.5.4 3s Bio Enbrel (Etanercept) and Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 3s Bio Recent Developments/Updates
2.6 Lupin
2.6.1 Lupin Details
2.6.2 Lupin Major Business
2.6.3 Lupin Enbrel (Etanercept) and Biosimilar Product and Services
2.6.4 Lupin Enbrel (Etanercept) and Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Lupin Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ENBREL (ETANERCEPT) AND BIOSIMILAR BY MANUFACTURER
3.1 Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Manufacturer (2018-2023)
3.2 Global Enbrel (Etanercept) and Biosimilar Revenue by Manufacturer (2018-2023)
3.3 Global Enbrel (Etanercept) and Biosimilar Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Enbrel (Etanercept) and Biosimilar by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Enbrel (Etanercept) and Biosimilar Manufacturer Market Share in 2022
3.4.2 Top 6 Enbrel (Etanercept) and Biosimilar Manufacturer Market Share in 2022
3.5 Enbrel (Etanercept) and Biosimilar Market: Overall Company Footprint Analysis
3.5.1 Enbrel (Etanercept) and Biosimilar Market: Region Footprint
3.5.2 Enbrel (Etanercept) and Biosimilar Market: Company Product Type Footprint
3.5.3 Enbrel (Etanercept) and Biosimilar Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Enbrel (Etanercept) and Biosimilar Market Size by Region
4.1.1 Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Region (2018-2029)
4.1.2 Global Enbrel (Etanercept) and Biosimilar Consumption Value by Region (2018-2029)
4.1.3 Global Enbrel (Etanercept) and Biosimilar Average Price by Region (2018-2029)
4.2 North America Enbrel (Etanercept) and Biosimilar Consumption Value (2018-2029)
4.3 Europe Enbrel (Etanercept) and Biosimilar Consumption Value (2018-2029)
4.4 Asia-Pacific Enbrel (Etanercept) and Biosimilar Consumption Value (2018-2029)
4.5 South America Enbrel (Etanercept) and Biosimilar Consumption Value (2018-2029)
4.6 Middle East and Africa Enbrel (Etanercept) and Biosimilar Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2029)
5.2 Global Enbrel (Etanercept) and Biosimilar Consumption Value by Type (2018-2029)
5.3 Global Enbrel (Etanercept) and Biosimilar Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2029)
6.2 Global Enbrel (Etanercept) and Biosimilar Consumption Value by Application (2018-2029)
6.3 Global Enbrel (Etanercept) and Biosimilar Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2029)
7.2 North America Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2029)
7.3 North America Enbrel (Etanercept) and Biosimilar Market Size by Country
7.3.1 North America Enbrel (Etanercept) and Biosimilar Sales Quantity by Country (2018-2029)
7.3.2 North America Enbrel (Etanercept) and Biosimilar Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2029)
8.2 Europe Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2029)
8.3 Europe Enbrel (Etanercept) and Biosimilar Market Size by Country
8.3.1 Europe Enbrel (Etanercept) and Biosimilar Sales Quantity by Country (2018-2029)
8.3.2 Europe Enbrel (Etanercept) and Biosimilar Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Enbrel (Etanercept) and Biosimilar Market Size by Region
9.3.1 Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Enbrel (Etanercept) and Biosimilar Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2029)
10.2 South America Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2029)
10.3 South America Enbrel (Etanercept) and Biosimilar Market Size by Country
10.3.1 South America Enbrel (Etanercept) and Biosimilar Sales Quantity by Country (2018-2029)
10.3.2 South America Enbrel (Etanercept) and Biosimilar Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Enbrel (Etanercept) and Biosimilar Market Size by Country
11.3.1 Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Enbrel (Etanercept) and Biosimilar Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Enbrel (Etanercept) and Biosimilar Market Drivers
12.2 Enbrel (Etanercept) and Biosimilar Market Restraints
12.3 Enbrel (Etanercept) and Biosimilar Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Enbrel (Etanercept) and Biosimilar and Key Manufacturers
13.2 Manufacturing Costs Percentage of Enbrel (Etanercept) and Biosimilar
13.3 Enbrel (Etanercept) and Biosimilar Production Process
13.4 Enbrel (Etanercept) and Biosimilar Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Enbrel (Etanercept) and Biosimilar Typical Distributors
14.3 Enbrel (Etanercept) and Biosimilar Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Enbrel (Etanercept) and Biosimilar
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Enbrel (Etanercept) and Biosimilar Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Syringe
1.3.3 Pen
1.4 Market Analysis by Application
1.4.1 Overview: Global Enbrel (Etanercept) and Biosimilar Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Pharmacy
1.4.4 Other
1.5 Global Enbrel (Etanercept) and Biosimilar Market Size & Forecast
1.5.1 Global Enbrel (Etanercept) and Biosimilar Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Enbrel (Etanercept) and Biosimilar Sales Quantity (2018-2029)
1.5.3 Global Enbrel (Etanercept) and Biosimilar Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Enbrel (Etanercept) and Biosimilar Product and Services
2.1.4 Pfizer Enbrel (Etanercept) and Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Pfizer Recent Developments/Updates
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen Enbrel (Etanercept) and Biosimilar Product and Services
2.2.4 Amgen Enbrel (Etanercept) and Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Amgen Recent Developments/Updates
2.3 Samsung Bioepis
2.3.1 Samsung Bioepis Details
2.3.2 Samsung Bioepis Major Business
2.3.3 Samsung Bioepis Enbrel (Etanercept) and Biosimilar Product and Services
2.3.4 Samsung Bioepis Enbrel (Etanercept) and Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Samsung Bioepis Recent Developments/Updates
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business
2.4.3 Novartis Enbrel (Etanercept) and Biosimilar Product and Services
2.4.4 Novartis Enbrel (Etanercept) and Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Novartis Recent Developments/Updates
2.5 3s Bio
2.5.1 3s Bio Details
2.5.2 3s Bio Major Business
2.5.3 3s Bio Enbrel (Etanercept) and Biosimilar Product and Services
2.5.4 3s Bio Enbrel (Etanercept) and Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 3s Bio Recent Developments/Updates
2.6 Lupin
2.6.1 Lupin Details
2.6.2 Lupin Major Business
2.6.3 Lupin Enbrel (Etanercept) and Biosimilar Product and Services
2.6.4 Lupin Enbrel (Etanercept) and Biosimilar Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Lupin Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: ENBREL (ETANERCEPT) AND BIOSIMILAR BY MANUFACTURER
3.1 Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Manufacturer (2018-2023)
3.2 Global Enbrel (Etanercept) and Biosimilar Revenue by Manufacturer (2018-2023)
3.3 Global Enbrel (Etanercept) and Biosimilar Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Enbrel (Etanercept) and Biosimilar by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Enbrel (Etanercept) and Biosimilar Manufacturer Market Share in 2022
3.4.2 Top 6 Enbrel (Etanercept) and Biosimilar Manufacturer Market Share in 2022
3.5 Enbrel (Etanercept) and Biosimilar Market: Overall Company Footprint Analysis
3.5.1 Enbrel (Etanercept) and Biosimilar Market: Region Footprint
3.5.2 Enbrel (Etanercept) and Biosimilar Market: Company Product Type Footprint
3.5.3 Enbrel (Etanercept) and Biosimilar Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Enbrel (Etanercept) and Biosimilar Market Size by Region
4.1.1 Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Region (2018-2029)
4.1.2 Global Enbrel (Etanercept) and Biosimilar Consumption Value by Region (2018-2029)
4.1.3 Global Enbrel (Etanercept) and Biosimilar Average Price by Region (2018-2029)
4.2 North America Enbrel (Etanercept) and Biosimilar Consumption Value (2018-2029)
4.3 Europe Enbrel (Etanercept) and Biosimilar Consumption Value (2018-2029)
4.4 Asia-Pacific Enbrel (Etanercept) and Biosimilar Consumption Value (2018-2029)
4.5 South America Enbrel (Etanercept) and Biosimilar Consumption Value (2018-2029)
4.6 Middle East and Africa Enbrel (Etanercept) and Biosimilar Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2029)
5.2 Global Enbrel (Etanercept) and Biosimilar Consumption Value by Type (2018-2029)
5.3 Global Enbrel (Etanercept) and Biosimilar Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2029)
6.2 Global Enbrel (Etanercept) and Biosimilar Consumption Value by Application (2018-2029)
6.3 Global Enbrel (Etanercept) and Biosimilar Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2029)
7.2 North America Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2029)
7.3 North America Enbrel (Etanercept) and Biosimilar Market Size by Country
7.3.1 North America Enbrel (Etanercept) and Biosimilar Sales Quantity by Country (2018-2029)
7.3.2 North America Enbrel (Etanercept) and Biosimilar Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2029)
8.2 Europe Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2029)
8.3 Europe Enbrel (Etanercept) and Biosimilar Market Size by Country
8.3.1 Europe Enbrel (Etanercept) and Biosimilar Sales Quantity by Country (2018-2029)
8.3.2 Europe Enbrel (Etanercept) and Biosimilar Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Enbrel (Etanercept) and Biosimilar Market Size by Region
9.3.1 Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Enbrel (Etanercept) and Biosimilar Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2029)
10.2 South America Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2029)
10.3 South America Enbrel (Etanercept) and Biosimilar Market Size by Country
10.3.1 South America Enbrel (Etanercept) and Biosimilar Sales Quantity by Country (2018-2029)
10.3.2 South America Enbrel (Etanercept) and Biosimilar Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Enbrel (Etanercept) and Biosimilar Market Size by Country
11.3.1 Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Enbrel (Etanercept) and Biosimilar Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Enbrel (Etanercept) and Biosimilar Market Drivers
12.2 Enbrel (Etanercept) and Biosimilar Market Restraints
12.3 Enbrel (Etanercept) and Biosimilar Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Enbrel (Etanercept) and Biosimilar and Key Manufacturers
13.2 Manufacturing Costs Percentage of Enbrel (Etanercept) and Biosimilar
13.3 Enbrel (Etanercept) and Biosimilar Production Process
13.4 Enbrel (Etanercept) and Biosimilar Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Enbrel (Etanercept) and Biosimilar Typical Distributors
14.3 Enbrel (Etanercept) and Biosimilar Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Enbrel (Etanercept) and Biosimilar Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Enbrel (Etanercept) and Biosimilar Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Enbrel (Etanercept) and Biosimilar Product and Services
Table 6. Pfizer Enbrel (Etanercept) and Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. Amgen Basic Information, Manufacturing Base and Competitors
Table 9. Amgen Major Business
Table 10. Amgen Enbrel (Etanercept) and Biosimilar Product and Services
Table 11. Amgen Enbrel (Etanercept) and Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Amgen Recent Developments/Updates
Table 13. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 14. Samsung Bioepis Major Business
Table 15. Samsung Bioepis Enbrel (Etanercept) and Biosimilar Product and Services
Table 16. Samsung Bioepis Enbrel (Etanercept) and Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Samsung Bioepis Recent Developments/Updates
Table 18. Novartis Basic Information, Manufacturing Base and Competitors
Table 19. Novartis Major Business
Table 20. Novartis Enbrel (Etanercept) and Biosimilar Product and Services
Table 21. Novartis Enbrel (Etanercept) and Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Novartis Recent Developments/Updates
Table 23. 3s Bio Basic Information, Manufacturing Base and Competitors
Table 24. 3s Bio Major Business
Table 25. 3s Bio Enbrel (Etanercept) and Biosimilar Product and Services
Table 26. 3s Bio Enbrel (Etanercept) and Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. 3s Bio Recent Developments/Updates
Table 28. Lupin Basic Information, Manufacturing Base and Competitors
Table 29. Lupin Major Business
Table 30. Lupin Enbrel (Etanercept) and Biosimilar Product and Services
Table 31. Lupin Enbrel (Etanercept) and Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Lupin Recent Developments/Updates
Table 33. Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 34. Global Enbrel (Etanercept) and Biosimilar Revenue by Manufacturer (2018-2023) & (USD Million)
Table 35. Global Enbrel (Etanercept) and Biosimilar Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 36. Market Position of Manufacturers in Enbrel (Etanercept) and Biosimilar, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 37. Head Office and Enbrel (Etanercept) and Biosimilar Production Site of Key Manufacturer
Table 38. Enbrel (Etanercept) and Biosimilar Market: Company Product Type Footprint
Table 39. Enbrel (Etanercept) and Biosimilar Market: Company Product Application Footprint
Table 40. Enbrel (Etanercept) and Biosimilar New Market Entrants and Barriers to Market Entry
Table 41. Enbrel (Etanercept) and Biosimilar Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Region (2018-2023) & (K Units)
Table 43. Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Region (2024-2029) & (K Units)
Table 44. Global Enbrel (Etanercept) and Biosimilar Consumption Value by Region (2018-2023) & (USD Million)
Table 45. Global Enbrel (Etanercept) and Biosimilar Consumption Value by Region (2024-2029) & (USD Million)
Table 46. Global Enbrel (Etanercept) and Biosimilar Average Price by Region (2018-2023) & (US$/Unit)
Table 47. Global Enbrel (Etanercept) and Biosimilar Average Price by Region (2024-2029) & (US$/Unit)
Table 48. Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 49. Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 50. Global Enbrel (Etanercept) and Biosimilar Consumption Value by Type (2018-2023) & (USD Million)
Table 51. Global Enbrel (Etanercept) and Biosimilar Consumption Value by Type (2024-2029) & (USD Million)
Table 52. Global Enbrel (Etanercept) and Biosimilar Average Price by Type (2018-2023) & (US$/Unit)
Table 53. Global Enbrel (Etanercept) and Biosimilar Average Price by Type (2024-2029) & (US$/Unit)
Table 54. Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 55. Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 56. Global Enbrel (Etanercept) and Biosimilar Consumption Value by Application (2018-2023) & (USD Million)
Table 57. Global Enbrel (Etanercept) and Biosimilar Consumption Value by Application (2024-2029) & (USD Million)
Table 58. Global Enbrel (Etanercept) and Biosimilar Average Price by Application (2018-2023) & (US$/Unit)
Table 59. Global Enbrel (Etanercept) and Biosimilar Average Price by Application (2024-2029) & (US$/Unit)
Table 60. North America Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 61. North America Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 62. North America Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 63. North America Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 64. North America Enbrel (Etanercept) and Biosimilar Sales Quantity by Country (2018-2023) & (K Units)
Table 65. North America Enbrel (Etanercept) and Biosimilar Sales Quantity by Country (2024-2029) & (K Units)
Table 66. North America Enbrel (Etanercept) and Biosimilar Consumption Value by Country (2018-2023) & (USD Million)
Table 67. North America Enbrel (Etanercept) and Biosimilar Consumption Value by Country (2024-2029) & (USD Million)
Table 68. Europe Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Europe Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Europe Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 72. Europe Enbrel (Etanercept) and Biosimilar Sales Quantity by Country (2018-2023) & (K Units)
Table 73. Europe Enbrel (Etanercept) and Biosimilar Sales Quantity by Country (2024-2029) & (K Units)
Table 74. Europe Enbrel (Etanercept) and Biosimilar Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Enbrel (Etanercept) and Biosimilar Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 77. Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 78. Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 79. Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 80. Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity by Region (2018-2023) & (K Units)
Table 81. Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity by Region (2024-2029) & (K Units)
Table 82. Asia-Pacific Enbrel (Etanercept) and Biosimilar Consumption Value by Region (2018-2023) & (USD Million)
Table 83. Asia-Pacific Enbrel (Etanercept) and Biosimilar Consumption Value by Region (2024-2029) & (USD Million)
Table 84. South America Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 85. South America Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 86. South America Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 87. South America Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 88. South America Enbrel (Etanercept) and Biosimilar Sales Quantity by Country (2018-2023) & (K Units)
Table 89. South America Enbrel (Etanercept) and Biosimilar Sales Quantity by Country (2024-2029) & (K Units)
Table 90. South America Enbrel (Etanercept) and Biosimilar Consumption Value by Country (2018-2023) & (USD Million)
Table 91. South America Enbrel (Etanercept) and Biosimilar Consumption Value by Country (2024-2029) & (USD Million)
Table 92. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 93. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 94. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity by Region (2018-2023) & (K Units)
Table 97. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity by Region (2024-2029) & (K Units)
Table 98. Middle East & Africa Enbrel (Etanercept) and Biosimilar Consumption Value by Region (2018-2023) & (USD Million)
Table 99. Middle East & Africa Enbrel (Etanercept) and Biosimilar Consumption Value by Region (2024-2029) & (USD Million)
Table 100. Enbrel (Etanercept) and Biosimilar Raw Material
Table 101. Key Manufacturers of Enbrel (Etanercept) and Biosimilar Raw Materials
Table 102. Enbrel (Etanercept) and Biosimilar Typical Distributors
Table 103. Enbrel (Etanercept) and Biosimilar Typical Customers
Table 1. Global Enbrel (Etanercept) and Biosimilar Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Enbrel (Etanercept) and Biosimilar Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Enbrel (Etanercept) and Biosimilar Product and Services
Table 6. Pfizer Enbrel (Etanercept) and Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Pfizer Recent Developments/Updates
Table 8. Amgen Basic Information, Manufacturing Base and Competitors
Table 9. Amgen Major Business
Table 10. Amgen Enbrel (Etanercept) and Biosimilar Product and Services
Table 11. Amgen Enbrel (Etanercept) and Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Amgen Recent Developments/Updates
Table 13. Samsung Bioepis Basic Information, Manufacturing Base and Competitors
Table 14. Samsung Bioepis Major Business
Table 15. Samsung Bioepis Enbrel (Etanercept) and Biosimilar Product and Services
Table 16. Samsung Bioepis Enbrel (Etanercept) and Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Samsung Bioepis Recent Developments/Updates
Table 18. Novartis Basic Information, Manufacturing Base and Competitors
Table 19. Novartis Major Business
Table 20. Novartis Enbrel (Etanercept) and Biosimilar Product and Services
Table 21. Novartis Enbrel (Etanercept) and Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Novartis Recent Developments/Updates
Table 23. 3s Bio Basic Information, Manufacturing Base and Competitors
Table 24. 3s Bio Major Business
Table 25. 3s Bio Enbrel (Etanercept) and Biosimilar Product and Services
Table 26. 3s Bio Enbrel (Etanercept) and Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. 3s Bio Recent Developments/Updates
Table 28. Lupin Basic Information, Manufacturing Base and Competitors
Table 29. Lupin Major Business
Table 30. Lupin Enbrel (Etanercept) and Biosimilar Product and Services
Table 31. Lupin Enbrel (Etanercept) and Biosimilar Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Lupin Recent Developments/Updates
Table 33. Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 34. Global Enbrel (Etanercept) and Biosimilar Revenue by Manufacturer (2018-2023) & (USD Million)
Table 35. Global Enbrel (Etanercept) and Biosimilar Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 36. Market Position of Manufacturers in Enbrel (Etanercept) and Biosimilar, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 37. Head Office and Enbrel (Etanercept) and Biosimilar Production Site of Key Manufacturer
Table 38. Enbrel (Etanercept) and Biosimilar Market: Company Product Type Footprint
Table 39. Enbrel (Etanercept) and Biosimilar Market: Company Product Application Footprint
Table 40. Enbrel (Etanercept) and Biosimilar New Market Entrants and Barriers to Market Entry
Table 41. Enbrel (Etanercept) and Biosimilar Mergers, Acquisition, Agreements, and Collaborations
Table 42. Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Region (2018-2023) & (K Units)
Table 43. Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Region (2024-2029) & (K Units)
Table 44. Global Enbrel (Etanercept) and Biosimilar Consumption Value by Region (2018-2023) & (USD Million)
Table 45. Global Enbrel (Etanercept) and Biosimilar Consumption Value by Region (2024-2029) & (USD Million)
Table 46. Global Enbrel (Etanercept) and Biosimilar Average Price by Region (2018-2023) & (US$/Unit)
Table 47. Global Enbrel (Etanercept) and Biosimilar Average Price by Region (2024-2029) & (US$/Unit)
Table 48. Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 49. Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 50. Global Enbrel (Etanercept) and Biosimilar Consumption Value by Type (2018-2023) & (USD Million)
Table 51. Global Enbrel (Etanercept) and Biosimilar Consumption Value by Type (2024-2029) & (USD Million)
Table 52. Global Enbrel (Etanercept) and Biosimilar Average Price by Type (2018-2023) & (US$/Unit)
Table 53. Global Enbrel (Etanercept) and Biosimilar Average Price by Type (2024-2029) & (US$/Unit)
Table 54. Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 55. Global Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 56. Global Enbrel (Etanercept) and Biosimilar Consumption Value by Application (2018-2023) & (USD Million)
Table 57. Global Enbrel (Etanercept) and Biosimilar Consumption Value by Application (2024-2029) & (USD Million)
Table 58. Global Enbrel (Etanercept) and Biosimilar Average Price by Application (2018-2023) & (US$/Unit)
Table 59. Global Enbrel (Etanercept) and Biosimilar Average Price by Application (2024-2029) & (US$/Unit)
Table 60. North America Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 61. North America Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 62. North America Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 63. North America Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 64. North America Enbrel (Etanercept) and Biosimilar Sales Quantity by Country (2018-2023) & (K Units)
Table 65. North America Enbrel (Etanercept) and Biosimilar Sales Quantity by Country (2024-2029) & (K Units)
Table 66. North America Enbrel (Etanercept) and Biosimilar Consumption Value by Country (2018-2023) & (USD Million)
Table 67. North America Enbrel (Etanercept) and Biosimilar Consumption Value by Country (2024-2029) & (USD Million)
Table 68. Europe Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Europe Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Europe Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 71. Europe Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 72. Europe Enbrel (Etanercept) and Biosimilar Sales Quantity by Country (2018-2023) & (K Units)
Table 73. Europe Enbrel (Etanercept) and Biosimilar Sales Quantity by Country (2024-2029) & (K Units)
Table 74. Europe Enbrel (Etanercept) and Biosimilar Consumption Value by Country (2018-2023) & (USD Million)
Table 75. Europe Enbrel (Etanercept) and Biosimilar Consumption Value by Country (2024-2029) & (USD Million)
Table 76. Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 77. Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 78. Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 79. Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 80. Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity by Region (2018-2023) & (K Units)
Table 81. Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity by Region (2024-2029) & (K Units)
Table 82. Asia-Pacific Enbrel (Etanercept) and Biosimilar Consumption Value by Region (2018-2023) & (USD Million)
Table 83. Asia-Pacific Enbrel (Etanercept) and Biosimilar Consumption Value by Region (2024-2029) & (USD Million)
Table 84. South America Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 85. South America Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 86. South America Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 87. South America Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 88. South America Enbrel (Etanercept) and Biosimilar Sales Quantity by Country (2018-2023) & (K Units)
Table 89. South America Enbrel (Etanercept) and Biosimilar Sales Quantity by Country (2024-2029) & (K Units)
Table 90. South America Enbrel (Etanercept) and Biosimilar Consumption Value by Country (2018-2023) & (USD Million)
Table 91. South America Enbrel (Etanercept) and Biosimilar Consumption Value by Country (2024-2029) & (USD Million)
Table 92. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2018-2023) & (K Units)
Table 93. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity by Type (2024-2029) & (K Units)
Table 94. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2018-2023) & (K Units)
Table 95. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity by Application (2024-2029) & (K Units)
Table 96. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity by Region (2018-2023) & (K Units)
Table 97. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity by Region (2024-2029) & (K Units)
Table 98. Middle East & Africa Enbrel (Etanercept) and Biosimilar Consumption Value by Region (2018-2023) & (USD Million)
Table 99. Middle East & Africa Enbrel (Etanercept) and Biosimilar Consumption Value by Region (2024-2029) & (USD Million)
Table 100. Enbrel (Etanercept) and Biosimilar Raw Material
Table 101. Key Manufacturers of Enbrel (Etanercept) and Biosimilar Raw Materials
Table 102. Enbrel (Etanercept) and Biosimilar Typical Distributors
Table 103. Enbrel (Etanercept) and Biosimilar Typical Customers
LIST OF FIGURES
Figure 1. Enbrel (Etanercept) and Biosimilar Picture
Figure 2. Global Enbrel (Etanercept) and Biosimilar Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Type in 2022
Figure 4. Syringe Examples
Figure 5. Pen Examples
Figure 6. Global Enbrel (Etanercept) and Biosimilar Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Pharmacy Examples
Figure 10. Other Examples
Figure 11. Global Enbrel (Etanercept) and Biosimilar Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Enbrel (Etanercept) and Biosimilar Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Enbrel (Etanercept) and Biosimilar Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Enbrel (Etanercept) and Biosimilar Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Enbrel (Etanercept) and Biosimilar by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Enbrel (Etanercept) and Biosimilar Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Enbrel (Etanercept) and Biosimilar Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Enbrel (Etanercept) and Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Enbrel (Etanercept) and Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Enbrel (Etanercept) and Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Enbrel (Etanercept) and Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Enbrel (Etanercept) and Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Enbrel (Etanercept) and Biosimilar Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Enbrel (Etanercept) and Biosimilar Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Region (2018-2029)
Figure 53. China Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Enbrel (Etanercept) and Biosimilar Market Drivers
Figure 74. Enbrel (Etanercept) and Biosimilar Market Restraints
Figure 75. Enbrel (Etanercept) and Biosimilar Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Enbrel (Etanercept) and Biosimilar in 2022
Figure 78. Manufacturing Process Analysis of Enbrel (Etanercept) and Biosimilar
Figure 79. Enbrel (Etanercept) and Biosimilar Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Enbrel (Etanercept) and Biosimilar Picture
Figure 2. Global Enbrel (Etanercept) and Biosimilar Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Type in 2022
Figure 4. Syringe Examples
Figure 5. Pen Examples
Figure 6. Global Enbrel (Etanercept) and Biosimilar Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Pharmacy Examples
Figure 10. Other Examples
Figure 11. Global Enbrel (Etanercept) and Biosimilar Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Enbrel (Etanercept) and Biosimilar Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Enbrel (Etanercept) and Biosimilar Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Enbrel (Etanercept) and Biosimilar Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Enbrel (Etanercept) and Biosimilar by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Enbrel (Etanercept) and Biosimilar Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Enbrel (Etanercept) and Biosimilar Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Enbrel (Etanercept) and Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Enbrel (Etanercept) and Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Enbrel (Etanercept) and Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Enbrel (Etanercept) and Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Enbrel (Etanercept) and Biosimilar Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Enbrel (Etanercept) and Biosimilar Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Enbrel (Etanercept) and Biosimilar Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Region (2018-2029)
Figure 53. China Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Enbrel (Etanercept) and Biosimilar Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Enbrel (Etanercept) and Biosimilar Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Enbrel (Etanercept) and Biosimilar Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Enbrel (Etanercept) and Biosimilar Market Drivers
Figure 74. Enbrel (Etanercept) and Biosimilar Market Restraints
Figure 75. Enbrel (Etanercept) and Biosimilar Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Enbrel (Etanercept) and Biosimilar in 2022
Figure 78. Manufacturing Process Analysis of Enbrel (Etanercept) and Biosimilar
Figure 79. Enbrel (Etanercept) and Biosimilar Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
